Advertisement
News
Subscribe to MDT Magazine News

Thomson Reuters Trademark Report Reveals New Challenges and Opportunities for Pharmaceutical Brands

June 8, 2011 8:34 am | by Bio-Medicine.Org | Comments

NEW YORK, June 8, 2011 /- According to a report published today by Thomson CompuMark, part of Thomson Reuters, the pharmaceutical industry has begun to adapt to stricter governmental brand name standards globally by rapidly increasing the number of trademarks it files for every new drug....

TOPICS:

Innovative Medical Products Showcased at MD & M East Ceremony

June 8, 2011 8:34 am | by Bio-Medicine.Org | Comments

NEW YORK, June 8, 2011 /- The winning products in this year's Medical Design Excellence Awards (MDEA) competition, presented by UBM Canon , received their gold or silver recognition at a ceremony held today during the Medical Design & Manufacturing East (MD&M East) 2011 Conference...

TOPICS:

LodgeNet Healthcare's eSUITE Solution Empowers Patients to Participate in Their Care

June 8, 2011 8:33 am | by Bio-Medicine.Org | Comments

SIOUX FALLS, S.D., June 8, 2011 /- As hospitals scramble to adopt the patient-centered focus that is at the heart of federal regulations and legislation aimed at improving healthcare in the U.S., LodgeNet Healthcare today announced the expansion of its interactive patient engagement...

TOPICS:
Advertisement

TSX little changed, oil prices surge as OPEC maintains production levels

June 8, 2011 6:45 am | by Malcolm Morrison-Associated Press | Comments

The Toronto stock market was little changed Wednesday with buying sentiment tempered by an acknowledgment from U.S. Federal Reserve chairman Ben Bernanke that U.S. economic growth remained "frustratingly slow." However, he said nothing to suggest the Fed was about to embark on any new stimulus...

Research Indicates a Strengthening U.S. Industrial Real Estate Market

June 8, 2011 6:35 am | by Material Handling Industry of America | Comments

Demand for logistics space is expected to accelerate over at least the next three quarters, according to the latest Prologis Industrial Business Indicator ("IBI") report. The IBI is a diffusion index that integrates customer-provided insights

Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products

June 8, 2011 6:34 am | by Bio-Medicine.Org | Comments

EAST BRUNSWICK, N.J. and EDISON, N.J., June 8, 2011 /- Amerigen Pharmaceuticals Limited and AustarPharma, LLC today announced they had entered into a broad-based collaboration agreement regarding the development of generic oral controlled release products. Under the terms of the...

TOPICS:

Upsher-Smith Receives Prestigious DIANA Award for Third Year in a Row

June 8, 2011 6:34 am | by Bio-Medicine.Org | Comments

MAPLE GROVE, Minn., June 8, 2011 /- Upsher-Smith Laboratories, Inc. announced today that it was honored with the prestigious Distribution Industry Award for Notable Achievements in Healthcare (DIANA) presented by the Healthcare Distribution Management Association (HDMA).  The award...

TOPICS:

Vycor Medical, Inc. Completes Equity Capital Raise

June 8, 2011 6:33 am | by Bio-Medicine.Org | Comments

BOCA RATON, Fla., June 8, 2011 /- On June 7, 2011, Vycor Medical, Inc.  ("Vycor" or the "Company") completed the sale of $1,570,000 in Units comprising Preferred Shares and Warrants (the "Units") to accredited investors (the "Investors").  The Units were issued pursuant to the...

TOPICS:
Advertisement

National Comprehensive Cancer Network Guidelines Available in Elekta's MOSAIQ EMR

June 8, 2011 6:32 am | by Bio-Medicine.Org | Comments

ATLANTA, June 8, 2011 /- Elekta has collaborated with the National Comprehensive Cancer Network® (NCCN®) to integrate the NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ™) into Elekta's MOSAIQ® Oncology Information System. The collaboration offers...

TOPICS:

Bellus Health posts Q1 profit of $3.3 million on accounting gain

June 8, 2011 5:45 am | by The Associated Press | Comments

Bellus Health Inc. (TSX:BLU) reports first-quarter net income of $3.3 million or a penny a share, compared with a loss of $3.76 million or two cents per share in the same 2010 quarter. The company did not report any revenue.

Otonomy Announces Preclinical Results Supporting Intra-operative Use of OTO-201 for Common Childhood Procedure

June 8, 2011 5:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, June 8, 2011 /- Otonomy, Inc., a developer of innovative therapeutics for diseases and disorders of the ear, today announced positive results for OTO-201, a sustained release gel formulation of the antibiotic ciprofloxacin, in multiple preclinical studies evaluating the...

XTRAC Laser Provides New Hope for Children with Psoriasis

June 8, 2011 5:33 am | by Bio-Medicine.Org | Comments

MONTGOMERYVILLE, Pa., June 8, 2011 /- About 20,000 children in the United States under the age of 10 are diagnosed with psoriasis every year. For many, the disease goes beyond painful red, dry patches of scaly, thickened skin; the emotional side-effects are equally life...

FDA Approves Updates to Lilly's Humalog® (insulin lispro injection rDNA origin) Label

June 8, 2011 5:33 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, June 8, 2011 /- Eli Lilly and Company (NYSE: LLY ) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental new drug application (sNDA) with the following updates to the Humalog label: continuous insulin infusion pump therapy in...

TOPICS:

Merck ends study of Staph infection vaccine

June 8, 2011 4:45 am | by The Associated Press | Comments

Merck & Co. and Intercell AG said Wednesday they have ended a trial of a potential vaccine for Staph infections because the vaccine was not working, and because patients who took the vaccine were more likely to die.The companies said a data monitoring committee unanimously recommended that they...

Grifols Announces Combined Operations With Talecris to Begin a New Era as a Global Leader of Life-Saving Plasma Therapeutics

June 8, 2011 3:35 am | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C., June 8, 2011 /- (NASDAQ: GRFS ) – Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain, today announced that it has officially begun to merge its operations with Talecris Biotherapeutics in order to function...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading